Eight Center for Immunology members has been awarded Seed Funds from Cornell University’s Office of Academic Integration. The grants will support a wide array of work from research on a Pan-Coronavirus vaccine to a project to develop a microbial delivery system for a unique treatment of colorectal cancer.
News
New view of lymph nodes shows immune cells in real time
Cornell researchers have for the first time imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy, which enabled them to observe the dynamic interactions of immune cells.
Targeting brain’s immune cells may block Alzheimer’s
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.
New RFA announced: Immunogenomic Collaborative Seed Grants
The Center for Immunology and the Genome Biology Task Force are excited to call for multi-investigator seed grant applications for innovative projects that will bring together researchers in genomics and immunology to tackle important questions and develop novel technologies to fuel discovery.
Cell-analysis technique could combat tuberculosis
A new method that analyzes how individual immune cells react to the bacteria that cause the disease could pave the way for new vaccine strategies, and provide insights into fighting other infectious diseases around the world.
Koretzky and August elected to AAI leadership
Two members of the Cornell Center for Immunology have been elected to leadership roles within the American Association of Immunologists.
Dr. Gary Koretzky was named AAI President for 2021-2022. In his first Presidents Message, Dr. Koretzky outlines his vision to advance the association’s mission through advocacy and public engagement, member and trainee support and educational programs, and more. Dr. Koretzky serves as the Cornell Center for Immunology’s Director, and the Vice Provost for Academic Integration at Cornell University, and a Professor of Medicine at Weill Cornell Medicine.
Dr. Avery August was appointed an Councilor for 2021-2025. Dr. August serves on the Cornell Center for Immunology’s Executive Committee and is a Vice Provost for Academic Affairs, HHMI Professor and Professor of Immunology with in the department of Microbiology and Immunology at Cornell University’s College of Veterinary Medicine.
Drs. Koretzky and August will serve on the AAI Council which is composed of eight scientists elected by voting AAI members. Forward-looking in their determination to answer the significant questions facing scientists, Council-members are charged to speak on behalf of the AAI membership and act in the best interests of AAI. These leaders of AAI are recognized experts in their specific fields and experienced administrators. They are, above all things, passionate about science and the belief that good science is critical in overcoming so many of the challenges we face today.
Geographic differences in gut microbiota boost immunity.
Cornell researchers “humanized” mice with microbiota from three global populations and found that microbial differences alone can impact immune responses.
Cancer vaccine improves outcomes in Lynch syndrome model
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
COVID-19 vaccines show safety, immunity in infant model
A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in preclinical research. There were no adverse effects.
SUNY chancellor recognizes faculty and staff with excellence awards
Two Center members have been selected for the 2020–21 State University of New York (SUNY) Chancellor’s Awards for Excellence. Brian Rudd, associate professor in the Department of Microbiology and Immunology, was a winner of the Chancellor’s Award for Excellence in Research and Scholarly Activity. John Parker, Ph.D. ’99, associate professor of virology at the Baker Institute for Animal Health, was a winner of the Chancellor’s Award for Excellence in Faculty Service.
